ensovibep – a journey from basic research to the development of a promising Covid-19 drug

Science Alumni UZH

In their public lecture, Prof. Andreas Plückthun, Professor for Biochemistry at the University of Zurich and co-founder of Molecular Partners, together with Dr. Michael Tobias Stumpp, Chief Operating Officer, member of the Management Board and co-founder of Molecular Partners AG, will provide insights into the history of the development of an innovative technology and of the promising drug, now licensed to Novartis AG.